» Articles » PMID: 37793808

A Critical Analysis of COVAX Alliance and Corresponding Global Health Governance and Policy Issues: a Scoping Review

Overview
Journal BMJ Glob Health
Specialty Public Health
Date 2023 Oct 4
PMID 37793808
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The COVAX alliance is a novel approach to international partnership in global health intended to achieve the worthy goal of 'COVID-19 vaccine equity'. This study aimed to identify the implementation challenges and framework gaps of COVAX and to explore the interconnected global health policy and governance gaps in ensuring equity, accessibility and affordability of vaccines.

Methods: A scoping review was conducted to identify the implementation challenges and framework gaps of COVAX and related global health policy and governance gaps. A search was carried out in PubMed, Scopus, Springer Link and Embase databases. Manually searched the grey literature, such as official reports and articles. EndNote V.20 was used to manage the evidence screening, and data extraction was carried out in Microsoft Excel.

Results: Searches of four electronic databases and official UN, GAVI and WHO websites identified 4686 pieces of evidence. The 937 duplicates were removed, and the remaining 3749 articles were screened for the title and abstract. Most articles were eliminated as they do not address global COVAX or COVID-19 vaccine equity. The remaining 53 pieces of evidence were reviewed for full text, and ultimately 40 articles found eligible were included in the scoping review.

Conclusions: The implementation challenges of COVAX were attributed mainly to the phenomenon of vaccine nationalism by rich countries. The future global health policy and governance structure must be re-examined to address the inadequacies of such novel super public-and-private partnership models.

Citing Articles

Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's....

Chattu V, Pushkaran A, Narayanan P Int J Health Policy Manag. 2024; 13:8578.

PMID: 39620545 PMC: 11365083. DOI: 10.34172/ijhpm.8578.


A Scoping Review of Factors Affecting COVID-19 Vaccination Uptake and Deployment in Global Healthcare Systems.

Kandulu C, Sahm L, Saab M, ODriscoll M, McCarthy M, Shorter G Vaccines (Basel). 2024; 12(10).

PMID: 39460261 PMC: 11511325. DOI: 10.3390/vaccines12101093.


'Our project, your problem?' A case study of the WHO's mRNA technology transfer programme in South Africa.

Herder M, Benavides X PLOS Glob Public Health. 2024; 4(9):e0003173.

PMID: 39312552 PMC: 11419367. DOI: 10.1371/journal.pgph.0003173.


COVID-19 Vaccination and Public Health: Addressing Global, Regional, and Within-Country Inequalities.

Santangelo O, Provenzano S, Di Martino G, Ferrara P Vaccines (Basel). 2024; 12(8).

PMID: 39204011 PMC: 11360777. DOI: 10.3390/vaccines12080885.


Financing pandemic prevention, preparedness and response: lessons learned and perspectives for future.

Ndembi N, Dereje N, Nonvignon J, Aragaw M, Raji T, Fallah M Global Health. 2024; 20(1):65.

PMID: 39169389 PMC: 11337782. DOI: 10.1186/s12992-024-01066-4.


References
1.
Li Z, Lu J, Lv J . The Inefficient and Unjust Global Distribution of COVID-19 Vaccines: From a Perspective of Critical Global Justice. Inquiry. 2021; 58:469580211060992. PMC: 8649905. DOI: 10.1177/00469580211060992. View

2.
Sekalala S, Forman L, Hodgson T, Mulumba M, Namyalo-Ganafa H, Meier B . Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine. BMJ Glob Health. 2021; 6(7). PMC: 8277484. DOI: 10.1136/bmjgh-2021-006169. View

3.
Lie R, Miller F . Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities. Milbank Q. 2020; 99(2):450-466. PMC: 8241277. DOI: 10.1111/1468-0009.12494. View

4.
Mukumbang F . Are asylum seekers, refugees and foreign migrants considered in the COVID-19 vaccine discourse?. BMJ Glob Health. 2020; 5(11). PMC: 7661346. DOI: 10.1136/bmjgh-2020-004085. View

5.
Usher A . Vaccine shortages prompt changes to COVAX strategy. Lancet. 2021; 398(10310):1474. PMC: 8530464. DOI: 10.1016/S0140-6736(21)02309-6. View